- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/05 - Virus Epstein-Barr
Détention brevets de la classe C07K 14/05
Brevets de cette classe: 176
Historique des publications depuis 10 ans
13
|
8
|
9
|
10
|
13
|
11
|
17
|
12
|
6
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
National Research Council of Canada | 1545 |
6 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
6 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 357 |
5 |
Baylor College of Medicine | 875 |
4 |
City of Hope | 943 |
4 |
Dana-Farber Cancer Institute, Inc. | 2455 |
4 |
Glaxosmithkline Biologicals S.A. | 1701 |
3 |
Wisconsin Alumni Research Foundation | 3774 |
3 |
The General Hospital Corporation | 4517 |
3 |
Cornell University | 3036 |
3 |
Deutsches Krebsforschungszentrum | 417 |
3 |
Les Hopitaux Universitaires de Geneve | 35 |
3 |
Universite de Geneve | 211 |
3 |
Sanofi | 3836 |
3 |
Centre National de La Recherche Scientifique | 9632 |
2 |
The Trustees of the University of Pennsylvania | 4122 |
2 |
University of Florida Research Foundation, Inc. | 3883 |
2 |
Bionor Immuno AS | 21 |
2 |
Cancer Research Technology Limited | 542 |
2 |
Institut Pasteur | 798 |
2 |
Autres propriétaires | 111 |